The main concern for me is people like Jason have done studies using data to show that SEID can diagnose even more people than under Fukuda which are too broad in my opinion.
An American advocate explained it well in this following comment:
“Data from a community‑based sample indicated that the SEID prevalence rate would be 2.8 times as great as the rate found when the Fukuda et al. criteria were applied. In addition, the erroneous inclusion of individuals with primary psychiatric conditions in SEID samples would have detrimental consequences for the interpretation of epidemiological, etiological, and treatment efficacy findings for people with this illness."
https://www.researchgate.net/public...e_IOM's_systemic_exertion_intolerance_disease
This means the majority of new SEID (ME/CFS) patients will have symptoms due to a variety of psychiatric, behavioral, and medical conditions previously excluded from Fukuda CFS. Given that not all people meeting the Fukuda criteria will also meet the SEID criteria, I calculated that about 75% of the new CDC ME/CFS (SEID) group will be people newly eligible for the diagnosis.
People with ME will be an even smaller percentage of the SEID group than currently of the Fukuda CFS group. I estimated less than about 20% of the new SEID (ME/CFS) mixed group will be people who should be diagnosed with ME.
New clinical trials of "ME/CFS" (SEID) treatments could show positive effects of exercise and CBT because a large portion of people given the new CDC ME/CFS diagnosis will actually have primary depressive disorders solely producing their symptoms.
Patients used for clinical trials are likely to be chosen from people diagnosed using the SEID criteria from clinical practices rather than subjects selected meeting more specific research criteria. The SEID criteria are already being promoted for research use by IOM panel members who claimed their broad criteria were not intended for research use. It makes no sense to have research conducted on groups of subjects differing widely from the group of patients given the diagnosis in clinical practice.
It will no longer be possible to argue that ME/CFS is a primarily physical disease because, in fact, a substantial portion of new CDC ME/CFS patients will have symptoms due to psychiatric disorders. Jason et al. found 47% of a sample of people with melancholic depression (a severe form of clinical depression excluded from Fukuda CFS) met the new CDC ME/CFS criteria.
The CDC and many prominent US CFS doctors and researchers (Montoya, Lipkin, Hornig, Bateman, and Klimas among others) are promoting the IOM criteria in research papers for diagnosis of "ME/CFS." The CDC on its website is now listing the Fukuda criteria for CFS, the CCC for ME/CFS, and the ICC for ME as "historic" criteria all replaced by the 2015 four-symptom IOM SEID criteria for what the CDC is now calling "ME/CFS."
This same person made this observation on oe